Cel-Sci Corporation

16.13-0.2200-1.35%Vol 334.57K1Y Perf 34.10%
Apr 9th, 2021 16:00 DELAYED
BID15.99 ASK16.13
Open16.33 Previous Close16.35
Pre-Market- After-Market16.59
 - -  0.46 2.85%
Target Price
19.00 
Analyst Rating
Strong Buy 1.00
Potential %
17.79 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/71/71 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-33/-33 
Growth Ranking
★+ —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-29/-29 
Income Ranking
 —    -
Market Cap653.73M 
Earnings Rating
Buy
Price Range Ratio 52W %
18.86 
Earnings Date
10th May 2021

Today's Price Range

15.7916.71

52W Range

10.3740.91

5 Year PE Ratio Range

-6.60-1.60

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-2.06%
1 Month
-11.76%
3 Months
16.04%
6 Months
8.47%
1 Year
34.10%
3 Years
883.54%
5 Years
9.36%
10 Years
-90.07%

TickerPriceChg.Chg.%
CVM16.13-0.2200-1.35
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Earnings HistoryEstimateReportedSurprise %
Q01 2021--0.21-
Q04 2020--0.14-
Q03 2020-0.15-0.27-80.00
Q02 2020-0.16-0.17-6.25
Q01 2020-0.15-0.16-6.67
Q04 2019-0.09-0.20-122.22
Q03 2019-0.10-0.37-270.00
Q02 2019-0.12-0.19-58.33
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.19--
6/2021 QR-0.13--
9/2021 FY-0.64--
9/2022 FY1.05--
Next Report Date10th May 2021
Estimated EPS Next Report-0.19
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume334.57K
Shares Outstanding40.53M
Trades Count3.63K
Dollar Volume22.16M
Avg. Volume1.09M
Avg. Weekly Volume538.10K
Avg. Monthly Volume732.98K
Avg. Quarterly Volume1.12M

Cel-Sci Corporation (AMEX: CVM) stock closed at 16.13 per share at the end of the most recent trading day (a -1.35% change compared to the prior day closing price) with a volume of 407.30K shares and market capitalization of 653.73M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 0 people. Cel-Sci Corporation CEO is Geert R. Kersten.

The one-year performance of Cel-Sci Corporation stock is 34.1%, while year-to-date (YTD) performance is 38.34%. CVM stock has a five-year performance of 9.36%. Its 52-week range is between 10.37 and 40.91, which gives CVM stock a 52-week price range ratio of 18.86%

Cel-Sci Corporation currently has a PE ratio of -17.70, a price-to-book (PB) ratio of 21.38, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -80.18%, a ROC of -99.50% and a ROE of -179.94%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Cel-Sci Corporation, there were 0 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.19 for the next earnings report. Cel-Sci Corporation’s next earnings report date is 10th May 2021.

The consensus rating of Wall Street analysts for Cel-Sci Corporation is Strong Buy (1), with a target price of $19, which is +17.79% compared to the current price. The earnings rating for Cel-Sci Corporation stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cel-Sci Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cel-Sci Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 25.60, ATR14 : 2.16, CCI20 : -57.63, Chaikin Money Flow : -0.42, MACD : -0.18, Money Flow Index : 46.02, ROC : -3.68, RSI : 47.25, STOCH (14,3) : 33.41, STOCH RSI : 0.28, UO : 37.76, Williams %R : -66.59), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cel-Sci Corporation in the last 12-months were: Bruno Baillavoine (Buy at a value of $9 416), John Cipriano (Sold 10 000 shares of value $127 290 ), Peter R. Young (Buy at a value of $44 827), Robert Watson (Buy at a value of $9 416)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Cel-Sci Corporation

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

CEO: Geert R. Kersten

Telephone: +1 703 506-9460

Address: 8229 Boone Boulevard, Vienna 22182, VA, US

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

62%38%

Bearish Bullish

52%48%

Bearish Bullish

61%39%

News

Stocktwits